Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone + Glyburide in African American and Hispanic T2DM
NCT00333723Phase 4Completed
- Sponsor
- GSK
- Start
- Jul 2000
- Primary completion
- Jan 2003
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of rosiglitazone in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Jul 2000; status: completed.
02
Drugs
rosiglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00333723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00333723.